Specialty Pharmacy

Patients put themselves at risk by not reading active ingredient listings on drug packaging.

Optic neuropathy is common in multiple sclerosis as the immune system destroys myelin and damages the nerves.

Recent advances and updates in oncology and cancer drug development.

HCV-related deaths continued to rise while deaths from 60 other infectious diseases declined.

Compounded hormone medications linked with potential risks and side effects.

Prescription drugs, over-the-counter drugs, and dietary supplements lead to potentially deadly combinations.

Sulindac and erlotinib effectively reduced the total duodenal polyps in patients with familial adenomatous polyposis.

Novel drug RG-101 could shorten the treatment time for hepatitis C virus (HCV) infection to 4 weeks.

Zepatier achieves sustained virologic response rate of 99.2% during a 12 to 16 week treatment course in patients with HCV.

Helping patients navigate manufacturer prescription assistance programs found to lower hospitalization costs.

Sugary drinks found to triple the risk of developing prostate cancer.

Top news of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Dietary intake of methionine and tryptophan may slow brain cancer tumor progression.

Single-cell method identifies core stem cells that cause leukemia within a tumor.

Pharmacists can aggressively intervene to adjust medications when patients’ diabetes is uncontrolled.

Higher consumer out-of-pocket costs could be a barrier to patient adoption of biosimilar drugs.

Ocrevus is a humanized monoclonal antibody that targets CD20-positive B cells in MS patients.

HCV testing rises in substance use disorder treatment programs.

Injections of new formulation of raltegravir may only be needed every month.

Ruptured cancerous cells are able to repair themselves to prevent cell death.

Zepatier boasts sustained virologic response rates of 99% in hepatitis C genotypes 1 and 4.

Top news of the day from across the health care landscape.

Multifaceted interventions with multiple members of the diabetes patient care team found more effective.

Work is still needed to achieve the significant promise of mobile health applications.

Specially synthesized plant peptide cyclotide found to suppress onset of multiple sclerosis.

Looming clinical trials offer hope for patients with Parkinson’s disease.

Study finds need for improved understanding of the association between rising systemic therapy use and the uptake of palliative care.